MannKind Corporation (NASDAQ:MNKD) VP Diane Palumbo sold 17,902 shares of the stock on the open market in a transaction dated Monday, June 16th. The shares were sold at an average price of $10.59, for a total value of $189,582.18. Following the sale, the vice president now directly owns 140,956 shares in the company, valued at approximately $1,492,724. MannKind Corporation (NASDAQ:MNKD) weekly performance is 7.57%. On last trading day company shares ended up $10.52. Analysts mean target price for the company is $9.06. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 36.33%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that its Annual Meeting of Stockholders will be webcast live on June 25, 2014. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares advanced 0.31% in last trading session and ended the day on $6.57. ARIA gross Margin is 79.20% and its return on assets is -66.50%.Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) quarterly performance is -19.19%.
Gilead Sciences, Inc. (NASDAQ:GILD) was having the best of times from last some months. But now it seems the real problem for the company is soon going to start. Its Sovaldi treatment is at the risk of rejection from the U.K. Cost Regulators. The regulator has made it clear that it can reject the $60,000 hepatitis C drug treatment. It will look out for details and will then decide over the matter. Accordingly, it will be decided if British government will pay for the treatment or not. Gilead Sciences, Inc. (NASDAQ:GILD) shares moved up 0.39% in last trading session and was closed at $79.78, while trading in range of $78.88 – $80.50. Gilead Sciences, Inc. (NASDAQ:GILD) year to date (YTD) performance is 6.23%.
A Delaware Chancery judge declined Wednesday to halt Danish pharmaceutical company H. Lundbeck A/S’ $658 million offer for Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) ruling that suing shareholders had not convinced him they’d be able to successfully show that Chelsea withheld important information about its potential value from investors. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) ended the last trading day at $6.55. Company weekly volatility is calculated as 0.41% and price to cash ratio as 13.94.Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) showed a positive weekly performance of 0.15%.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) is accused of violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, after issuing a stern rebuke by MD Anderson Cancer Center for making unjustifiable claims concerning the current trail of DCVax-Direct cancer vaccine. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) weekly performance is -0.14%. On last trading day company shares ended up $7.18. Analysts mean target price for the company is $10.05. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) distance from 50-day simple moving average (SMA50) is 16.88%.
Leave a Reply